Hypotyreosis and Thyroxin purchase for inclusion criteria

HYPOT_THYRO_INCL

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 E03
Cause of death: ICD-10 E03
Medicine purchases: ATC H03AA01

46992

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

43407

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

43407

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

43497

diagram downward connector
HYPOT_THYRO_INCL

Extra metadata

First used in FinnGen datafreeze DF8

Similar endpoints

List of similar endpoints to Hypotyreosis and Thyroxin purchase for inclusion criteria based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 43497 34694 8803
Unadjusted prevalence (%) 12.23 17.49 5.59
Mean age at first event (years) 51.65 50.00 58.14

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.03 1.57 [1.38, 1.78] 3.5e-12 3291
15 years 0.01 1.09 [0.97, 1.23] 1.4e-1 1603
5 years 0.00 1.92 [1.71, 2.15] 1.5e-28 802
1 year 0.00 1.93 [1.59, 2.35] 5.0e-11 145

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: HYPOT_THYRO_INCL – Hypotyreosis and Thyroxin purchase for inclusion criteria
GWS hits:

Survival analyses between endpoints

Plot

before Hypotyreosis and Thyroxin purchase for inclusion criteria
after Hypotyreosis and Thyroxin purchase for inclusion criteria

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hypotyreosis and Thyroxin purchase for inclusion criteria